Tick Tech: Biotech Tools Give New Hope For Those With Lyme Disease
The most common tick-borne illness in the U.S. (30,000+ new cases a year), Lyme disease produces a wide range of symptoms ranging from fever and rash to arthritis and paralysis. Thanks to biotech, genome sequencing and precision medicine, prevention, early detection and treatment are now possible.
Source: Forbes.com Healthcare News - Category: Pharmaceuticals Authors: Nicole Fisher, Contributor Source Type: news
More News: Arthritis | Biotechnology | Lyme Disease | Pharmaceuticals | Rheumatology | Tickborne Diseases